Sachetta’s XBiotech XBIT Stock Holding History

Sachetta’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$324	–	1198
2025 Q1	$324	Hold	100	–	–	﹤0.01%	1065
2024 Q4	$395	Hold	100	–	–	﹤0.01%	1111
2024 Q3	$773	Buy	+100	New	+$657	﹤0.01%	1072

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sachetta's XBIT Position: Q2 2025 in Review

Sachetta sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 100 shares — an estimated $324 sold.

Sachetta first reported a position in XBIT in Q3 2024 and held it in 3 quarters. The position peaked at $773 in Q3 2024. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

Sachetta reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
Sachetta sold 100 XBiotech shares in Q2 2025, an estimated $324.
Sachetta first reported a position in XBiotech in Q3 2024 and held it in 3 quarters.
Sachetta's XBiotech position peaked at $773 in Q3 2024.
53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Sachetta's 13F filing for Q2 2025, filed 23 Jul 2025.